<SEC-DOCUMENT>0001437749-22-002379-index.html : 20220203
<SEC-HEADER>0001437749-22-002379.hdr.sgml : 20220203
<ACCEPTANCE-DATETIME>20220203163116
ACCESSION NUMBER:		0001437749-22-002379
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20220127
FILED AS OF DATE:		20220203
DATE AS OF CHANGE:		20220203

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Garlikov Julie
		CENTRAL INDEX KEY:			0001793266

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33678
		FILM NUMBER:		22588885

	MAIL ADDRESS:	
		STREET 1:		2420 17TH STREET
		STREET 2:		SUITE 220
		CITY:			DENVER
		STATE:			CO
		ZIP:			80202

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NovaBay Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001389545
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				680454536
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		(510) 899-8800

	MAIL ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>rdgdoc.xml
<DESCRIPTION>FORM 3
<TEXT>
Document 1 - file: rdgdoc.html

Document 1 - RAW XML: rdgdoc.xml

</DOCUMENT>
</SEC-DOCUMENT>